CORAT lead product COR-101 ready for clinical trials

CORAT lead product COR-101 ready for clinical trials

15.11.2020 – CORAT Therapeutics CEO Dr. Andreas Herrmann today proudly reports the conclusion of the production campaign providing the first larger batch of COR-101 ready for the patients. COR-101 is a fully human antibody developed in Braunschweig which...
CORAT Therapeutics founded

CORAT Therapeutics founded

With support from the German Federal State of Lower Saxony, CORAT Therpeutics was formed as a dedicated body to promote the further development of the antibody based COVID-10 medicine. “What is being developed here in Braunschweig may save lives all over the...